New approaches to the evaluation of the metastatic ability of renal cancer and new approaches to chemotherapy.
Isaacs
W B
WB
Johns Hopkins Oncology Center, Johns Hopkins School of Medicine, Baltimore, Md.
Isaacs
J T
JT
Kyprianou
N
N
Burgers
J K
JK
Alexander
R B
RB
Partin
A W
AW
Mohler
J L
JL
Marshall
F F
FF
Coffey
D S
DS
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary*; D002465:Cell Movement / Q000502:physiology; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage
D014409:Tumor Necrosis Factor-alpha; D005047:Etoposide